Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 10, 2026

Hemagen Diagnostics Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2012FY 2011FY 2010FY 2009FY 2008
Period Ending
Sep '12 Sep '11 Sep '10 Sep '09 Sep '08
Cash & Equivalents
0.070.210.150.160.1
Cash & Short-Term Investments
0.070.210.150.160.1
Cash Growth
-68.97%40.77%-2.92%58.21%1398.77%
Accounts Receivable
0.590.580.670.630.87
Receivables
0.590.620.880.841.08
Inventory
1.361.461.391.72.04
Prepaid Expenses
0.080.160.350.120.3
Total Current Assets
2.092.452.772.823.52
Property, Plant & Equipment
0.280.390.530.60.7
Other Long-Term Assets
0.070.050.040.050.1
Total Assets
2.442.893.373.724.77
Accounts Payable
0.370.420.310.560.74
Accrued Expenses
0.520.340.290.310.22
Short-Term Debt
0.980.670.40.40.5
Current Portion of Long-Term Debt
---0.034.01
Current Income Taxes Payable
0.060.060.140.10.17
Current Unearned Revenue
0.020.040.030.050.1
Total Current Liabilities
1.951.531.171.455.74
Long-Term Debt
4.054.054.054.050.12
Total Liabilities
65.585.225.55.86
Common Stock
0.160.160.160.150.15
Additional Paid-In Capital
23.1323.0422.9622.9222.87
Retained Earnings
-26.68-25.77-24.89-24.73-23.93
Treasury Stock
-0.09-0.09-0.09-0.09-0.09
Comprehensive Income & Other
-0.08-0.020.02-0.03-0.1
Shareholders' Equity
-3.56-2.69-1.85-1.78-1.09
Total Liabilities & Equity
2.442.893.373.724.77
Total Debt
5.034.724.454.484.63
Net Cash (Debt)
-4.96-4.51-4.3-4.32-4.53
Net Cash Per Share
-0.32-0.29-0.28-0.28-0.30
Filing Date Shares Outstanding
15.515.4915.4715.2515.23
Total Common Shares Outstanding
15.515.4915.4715.2515.23
Working Capital
0.150.921.61.37-2.23
Book Value Per Share
-0.23-0.17-0.12-0.12-0.07
Tangible Book Value
-3.56-2.69-1.85-1.78-1.09
Tangible Book Value Per Share
-0.23-0.17-0.12-0.12-0.07
Machinery
6.696.726.736.676.59
Leasehold Improvements
0.10.10.090.080.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.